Navigation Links
Fauve Intertrade Signs Major Energy Contracts in China
Date:9/3/2009

BEIJING, Sept. 3 /PRNewswire/ -- Fauve Intertrade Corporation, led by Chairman/CEO Oscar C. Fields and President Chung Leik Kok, announced today the signing of two (2) major energy contracts to sell energy products to United China Petroleum and Chemical Co., Ltd. (Beijing Oil & Gas). Fauve Intertrade is a privately held corporation with managing offices in Raleigh, North Carolina; Miami, Florida; and Kuala Lumpur, Malaysia - with offices opening in the Fall of 2009 in Beijing, China; Argentina; and Brazil. The Asian division will be managed by Chung Leik Kok, while the Latin American division will be managed by Antonio Garcia. Fauve Intertrade is a producer and distributor of bio fuels, agricultural commodities and fossil fuels, and specializes in the operation of cargo/passenger charters.

United China Petroleum and Chemical Co., Ltd. (Beijing Oil & Gas), led by Chairman Dongming Yu, is one of the major energy companies in China and controls one of three energy licenses in addition to managing over sixty (60) refineries of various energy products.

The contracts entered into by the two companies call for an estimated sale of $600 Million US Dollars per month for the delivery of energy products to China via its major ports. The contract term is for five (5) years with an option to renew on mutually agreed terms. Fauve Intertrade and United China Petroleum & Chemical Co. estimate the contract will generate $36 billion US Dollars in sales over this period.

Picture #1: Chairman/CEO Oscar C. Fields and President Chung Leik Kok of Fauve Intertrade Corporation (right) sign energy contract with Chairman Yu Dongming (left) of United China Petroleum and Chemical Co., Ltd. (Beijing Oil & Gas) at contract signing ceremony in Beijing, China -http://www.ereleases.com/pr/2009-Fauve.jpg

Picture #2: Chairman/CEO Oscar C. Fields of Fauve Intertrade Corporation (left) and Chairman Yu Dongming (right) of United China Petroleum and Chemical Co., Ltd. (Beijing Oil & Gas) shake hands at contract signing ceremony in Beijing, China -http://www.ereleases.com/pr/2009-Fauve-2.jpg

    Contact Information:

    Oscar Fields
    United States Contact
    1 (919) 882-2092
    1 (919) 697-1254 (mobile)

    Chung Leik Kok
    Asia Contact
    +601 230 76746
    +86 13552327380 (mobile)

This release was issued through eReleases(TM). For more information, visithttp://www.ereleases.com.


'/>"/>
SOURCE Fauve Intertrade Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. SynCo Bio Partners Enters the Japanese Market as it Signs its First Agreement With a Japanese Pharmaceutical Company
2. Martek Signs Sole-Source Supply Agreement with Milk Powder Solutions
3. Martek Signs Sole-Source ARA Supply Agreement with Puleva Food S.L.
4. Dendreon Signs Lease for New Manufacturing Facility in Atlanta
5. Alexandria Real Estate Equities, Inc. Signs Biopharmaceutical Company, Lilly, as Anchor New York City Tenant at the Alexandria Center for Science and Technology
6. Hygeia Therapeutics Signs an Exclusive License with Yale University for Potent, Safe Topical Anti-Androgens
7. avVaa World Health Care Products, Inc. Signs Agreement with 3PL Worldwide, Inc., for Order Management & Fulfillment for avVaas Product
8. CEL-SCI Signs Definitive Agreement to Raise $5 Million in Registered Direct Offering
9. New Generation Biofuels Signs Letter of Intent with Instituto Costarricense de Electricidad (ICE) of Costa Rica
10. GeoVax Signs HIV/AIDS Vaccine Proposal With Health and Hospital System of Cook County, Illinois
11. SEP Signs REGURIN(R) Deal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... the release of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” ... and retention in this eBook by providing practical tips, tools, and strategies for ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... -- A person commits a crime, and the detective uses ... criminal down. An outbreak of foodborne illness makes ... uses DNA evidence to track down the bacteria that caused ... not. The FDA has increasingly used a complex, cutting-edge technology ... Put as simply as possible, whole genome sequencing is a ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute approval ... of microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory ...
Breaking Biology Technology:
(Date:3/31/2016)... , March 31, 2016   ... ("LegacyXChange" or the "Company") LegacyXChange is excited ... of its soon to be launched online site for ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders a ... DNA technology to an industry that is notorious for ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
(Date:3/22/2016)... 22, 2016 According ... Market for Consumer Industry by Type (Image, Motion, ... (Communication & IT, Entertainment, Home Appliances, & ... to 2022", published by MarketsandMarkets, the market ... reach USD 26.76 Billion by 2022, at ...
Breaking Biology News(10 mins):